Litigation Follows OTC Eye Drops Recall Due To Bacteria Strain Not Previously Seen In US
Complaints Against EzriCare, Delsam, Aru Pharma Follow US Warning To Manufacturer In India
Following a recall earlier in February of EzriCare’s and Delsam’s OTC artificial tears due to potential bacterial contamination, plaintiffs’ bar steps in with first of what may be multiple lawsuits. CDC says drug-resistant strain of Pseudomonas aeruginosa bacteria not previously seen in US.